维普中文期刊产品整合服务
37篇 您的检索式:作者名="SL Lam"
    题名 作者 年代 出处 被引量
1High dosage of Exendin-4 increased early insulin secretion in differentiated beta cells from mouse embryonic stem cells显示文摘Hua LI Amy LAM Ai-min XU Karen SL LAM Sookja KIM CHUNG 2010Acta Pharmacologica Sinica2010,31,5:10
2Adiponectin as a negative regulator in obesity-related mammary carcinogenesis显示文摘肥胖和它的联系疾病的流行在我们的社会上提出了巨大的保健影响。肥胖为许多严重医药条件是 maj 或风险因素,例如新陈代谢的症候群,类型 2 糖尿病和心血管的混乱等等。Inaddition,有癌症的肥胖的靠近的协会吸引了重要注意。包括胸,前列腺,子宫内膜,冒号和胆囊癌症,几肥胖相关的癌症有一个神经质的基础并且是生命风格相关。乳癌是最经常的癌症和在女人之中的癌症死亡的第二个领先的原因。在 pre- andpost-menopausal 年的过量脂肪过多是为乳癌的发展的一个独立风险因素,并且也与迟了阶段的疾病和差的预后被联系。Yu Wang 2007Cell Research2007,17,4:3
3The clinical value of autofluorescence bronchoscopy for the diagnosis of lung cancer 显示文摘Lam B Wong MP Fung SL 2006Eur Respir J2006,28,5:1
4Spontaneous neonatal chylothorax treated with octreotide显示文摘Siu SL Lam DS 2006J Paediatr Child Health2006,42,12:1
5Foetal exposure to maternal passive smoking is associated with childhood asthma, allergic rhinitis, and eczema 显示文摘Lee SL Lam TH Leung TH 2012Scientific World Journal2012,,54:1
6Paratubal cyst complicated by tubo-ovarian torsion:computed tomography features显示文摘SCA Low CL Ong SL Lam 2005Australas Radiol2005,49,2:1
7TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand显示文摘Lam J Takeshita S Barker JE Kanagawa O Ross FP Teitelbaum SL 0,,:1
8Association between tumor necrosis factor alpha promoter polymorphisms and Alzheimer's disease显示文摘Ma SL Tang NL Lam LC 2004Neurology2004,62,2:1
9Clinical experience with autoflourescence bronchoscopy for the diagnosis of lung cancer显示文摘Lam B Wong MP fung SL 2006Eur Respir J2006,28,5:1
10The association between promoter polymorphism of the interleukin-10 gene and Alzheimer's disease显示文摘Ma SL Sang Tang NL Wa Lam LC 2005Neurobiology of Aging2005,26,:1
11The association between promoter polymorphism of the interleukin-10 gene and alzheimer' s disease 显示文摘Ma SL Tang NL Lam LC 2005Neurobiol Aging2005,26,7:1
12Spontaneous neonatal chylothorax treated with oct reotide显示文摘Siu SL Lam DS 2006J Paediatr Child Heahh2006,42,12:1
13A prospective randomized study on three different peritoneal dialysis catheters显示文摘Lo WK Lui SL Li FK Choy BY Lam MF 2003Perit Dial Int2003,232,:1
14Imaging findings in acute neck infection due to pyri- form sinus fistula显示文摘Gan YU Lam SL 2004Annals of the Academy of Medicine Singapore2004,33,5:1
15Cytokeratin expression in non-neoplastic oesophageal epithelium and squamous cell carcinoma of the oesophagus显示文摘Lam KY Loke SL Shen XC 1995Virchows Archiv1995,426,6:1
16Clinical experience with autoflo-urescence bronchoscopy for the diagnosis of lung cancer显示文摘Lam B Wong MP Fung SL 2006Eur Respir J2006,28,5:1
17Pregnancy luteoma presenting as ovar- ian torsion with rupture and intra-abdominal bleeding 显示文摘Tan ML Lam SL Nadarajah S 2008Singapore Med J2008,49,3:1
18Metabolic actions of FGF21:molecular mechanisms and therapeutic implications显示文摘Fibroblast growth factor 21(FGF21)is an atypical member of the FGF family that functions as an endocrine factor.In obese animals,elevation of plasma FGF21 levels by either pharmacological or genetic approaches reduces body weight,decreases hyperglycemia and hyperlipidemia,alleviates fatty liver and increases insulin sensitivity.FGF21 exerts its pleiotropic metabolic effects through its actions on multiple targets,including adipose tissue,liver,brain and pancreas.The expression of FGF21 is under the control of both peroxisome proliferator-activated receptor gamma(PPARγ)and peroxisome proliferator.-activated receptor alpha(PPARα).A growing body of evidence suggests that the metabolic benefits of these two nuclear receptors are mediated in part by induction of FGF21.In humans,plasma levels of FGF21 are elevated in obese subjects and patients with type 2 diabetes,but are reduced in patients with autoimmune diabetes.This review summarizes recent advances in understanding the physiological roles of FGF21 and the molecular pathways underlying its actions,and also discusses the future prospective of developing FGF21 or its agonists as therapeutic agents for obesity-related medical complications.Xuan Ge Yu Wang Karen SL Lam Aimin Xu 2012Acta Pharmaceutica Sinica B2012,2,4:1
19Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis 显示文摘Lam RW Lonn SL Despiegel N 2010Int Clin Psychopharmacology2010,25,:1
20The use of a distal occlusion balloon protection device in acute coronary syndrome显示文摘Steven SL Li CW Lam YC 2003Inter J Cardiol2003,92,7:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费